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Abstract
As a major component of the innate immune system, natural killer cells are responsible for activating the cytolytic killing of
certain pathogen-infected or tumor cells. The self-recognition of natural killer cells is achieved in part by the killer cell
immunoglobulin-like receptors (KIRs) protein family. In the current study, using a suite of biophysical methods, we
investigate the self-association of an activating KIR, KIR2DS1. This KIR is of particular interest because when in the presence
of the HLA-Cw6 protein, KIR2DS1 becomes a major risk factor for psoriasis, an autoimmune chronic skin disease. Using
circular dichroism spectroscopy, dynamic light scattering, and atomic force microscopy, we reveal that KIR2DS1 self-
associates in a well-defined fashion. Our novel results on an activating KIR allow us to suggest a working model for the
KIR2DS1- HLA class I molecular mechanism.
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Introduction
The innate immune system provides immediate defense against
infection. Natural Killer (NK) cells are a major component of the
innate immune system and are responsible for activating the
cytolytic killing of certain pathogen-infected or tumor cells. It is
essential for the NK cells to discriminate between self- and non-self
to ensure that NK-mediated lysis occurs against the appropriately
targeted cells. The self-recognition of NK cells is achieved in part
by receptors that recognize MHC class I molecules (HLA-A,
HLA-B, and HLA-C) on self-cells [1]. To date, three distinct
families of MHC class I – recognizing NK cell receptors have been
indentified; Ly49, CD94/NKG2, and killer cell immunoglobulin-
like receptors (KIRs) [2].
Killer cell immunoglobulin-like receptors are type I transmem-
brane glycoproteins that contain two or three extracellular
immunoglobulin (Ig) domains with either long (2DL, 3DL) or
short (2DS, 3DS) cytoplasmic tails [3,4,5]. Receptors with long
tails are inhibitory, while receptors with short tails are activating.
Long tail receptors contain an immunoreceptor tyrosine-based
inhibitory motif (ITIM) that contributes to the inhibitory signal,
and is essential for recognizing self-cells. The activating KIRs
(2DS1, 2DS2, and 3DS1) are associated with DAP12, which
participates in signaling events, such as cytolysis. However, much
less is known about the biological role of the activating, short-tail
receptors compared to their inhibitory counterparts.
Combinations of certain KIRs and MHC class I molecules, such
as HLA-Cw6 and KIR2DS1, have been linked with susceptibility
to autoimmune diseases, inlcuding psoriasis. Psoriasis is a lifelong
skin disease that affects an estimated 1 to 3% of the world’s
population. Recognized as the most prevalent autoimmune
disease, psoriasis is caused by inappropriate activation of the
cellular immune system [6]. This disease is complex and results
from an interplay between multiple genetic and environmental
factors [7]. These factors lead to an aggravated state of innate
immunity characterized by the activity of natural killer (NK) T
cells, dendritic cells, neutrophils, and keratinocytes [8]. More
specifically, the presence of the HLA-Cw6 protein in combination
with its receptor, KIR2DS1, is a major risk factor for psoriasis [9].
In fact, ,50% of psoriasis patients carry the HLA-Cw6 gene and
these individuals usually have a younger age of onset and an
increased disease severity [10]. Therefore, it is important to
understand the molecular mechanism of KIR2DS1.
In the present work we have characterized KIR2DS1 using a
suite of biophysical methods. We provide evidence that the
purified extracellular portion of the protein self-associates under
many different conditions. Using circular dichroism spectroscopy,
dynamic light scattering and atomic force microscopy, we revealed
the first direct evidence that KIR2DS1 self-associates in a well-
defined fashion.
Materials and Methods
KIR2DS1 expression and purification
cDNA (bacteria codon optimized) encoding the extracellular region
of KIR2DS1 (MAHEGVHRKPSLLAHPGRLVKSEETVILQC-
WSDVMFEHFLLHREGMFNDTLRLIGEHHDGVSKANFSISR-
MRQDLAGTYRCYGSVTHSPYQLSAPSDPLDIVIIGLYEKPS-
LSAQPGPTVLAGENVTLSCSSRSSYDMYHLSREGEAHERR-
LPAGTKVNGTFQANFPLGPATHGGTYRCFGSFRDSPYEWS-
KSSDPLLVSVTLVPRGS), plus a C-terminal 6-His tag, inserted into
a PET23d(+) vector was purchased from GenScript (Piscataway, NJ,
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USA). The plasmid was then transformed into BL21 competent
Escherichia coli cells for large scale expression of KIR2DS1. Cells were
grown at 37uC to an OD of 0.6, induced with 1 mM IPTG and
harvested after 3 hours.
The harvested BL21 cells were lysed using a French pressure
cell and solubilized in 8 M urea, 100 mM Tris-HCl (pH 8.0) and
1 mM DTT. The resulting supernatant, containing KIR2DS1,
was loaded onto an equilibrated Ni2+-nitrilotriacetic acid- agarose
column (5 ml) and washed with five column volumes of 10 mM
Tris-HCl (pH 8.0), 100 mM sodium chloride and 8 M urea.
KIR2DS1 was eluted using an imidazole gradient and the purified
protein-containing fractions were pooled.
The purified protein was put through a series of dialysis steps,
following the method of Stewart et al. [11], to ensure proper
refolding. The denatured protein in 8 M urea was intially dialyzed
against a series of 4 buffers containing 20 mM Tris-HCl (pH 7.8),
150 mM sodium chloride, 400 mM arginine, 1 mM b-mercapto-
ethanol and decreasing urea concentrations of 4, 3, 2 and 1 M.
The protein was then dialyzed against 0.5 and 0 M urea in
20 mM Tris-HCl (pH 7.8), 150 mM sodium chloride, 400 mM
arginine, 1 mM b-mercaptoethanol, 5 mM reduced glutathione,
0.5 mM oxidized glutathione and 0.4 mM sodium azide. The last
step was dialysis against 10 mM Tris-HCl, 150 mM sodium
chloride and 0.4 mM sodium azide.
Microdrop Sceeening
Microdrop screening was used to detect KIR2DS1 aggregation
as described by Lepre and Moore [12]. We tested 23 different buffer
conditions with a 24 well tissue culture plate and siliconized glass
cover slips. 1 mL of each buffer was pipetted into each reservoir,
and then, 2 mL aliquots of protein solution in starting buffer were
pipetted onto the glass coverslips. 1 mL of each of reservoir buffer
was added to each drop, and the solutions were mixed by gently
drawing and expelling the solution in the pipette tip. The glass slips
were then inverted and sealed onto the wells using petroleum jelly.
The plate was allowed to rest undisturbed at room temperature so
that vapor diffusion could take place. Precipitate in the drops were
detected by placing the tray against a black background, iluminating
Figure 1. (A) Far-UV circular dichroism spectra of KIR2DS1 (3 mM, freshly refolded). (B) Secondary structural content of KIR2DS1.
Secondary structural content was calculated as described in Materials and Methods.
doi:10.1371/journal.pone.0023052.g001
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it from the slide, and visually examining each drop under a
microscope. Under these lighting conditions, precipitate appears as
a white spot against the black background.
Size Measurements
The size of KIR2DS1 was measured in a Zetasizer Nano ZS
instrument (Malvern Instruments Ltd., Worcestershire, U.K.) in
the presence of 10 mM Tris-HCl, 150 mM sodium chloride and
0.4 mM sodium azide. Measurements were taken at 25uC.
Circular dichroism spectroscopy
Circular dichroism spectra in the far-ultraviolet were recorded using
a Jasco-810 spectrapolarimeter (Applied Photophysics, UK). The
absorbance at 222 nm of the protein/reagents mixture was checked to
ensure that it did not exceed an optical density of 1.0. A 1 mm cell was
used and spectra were collected between 200 and 250 nm. Baselines
were established using the appropriate buffer (10 mM Tris-HCl,
150 mM sodium chloride and 0.4 mM sodium azide) and 5 spectra
were collected for each sample and averaged. Secondary structure
content was calculated from the collected spectra using a computer
program following the method of Hennessey and Johnson [13].
Atomic force microscopy (AFM)
All experiments were conducted in a solution of 10 mM Tris-
HCl, 150 mM sodium chloride and 0.4 mM sodium azide on
freshly cleaved mica surfaces at room temperature. Imaging was
performed on an MFP-3D (Asylum Research Inc) in contact mode
using gold-coated, silicon cantilevers (Micromasch). Images are
presented with minimal post-processing with a simple planefit used
to correct for curvature.
Results
KIR2DS1 conformation
A freshly refolded KIR2DS1 sample was centrifuged and the
supernatant (3 mM) was retained. A circular dichroism spectrum of
the above sample was recorded at pH 7.5 and 25uC (Figure 1A).
Secondary structure content was calculated from the CD-spectrum
using a computer program that followed the method of Hennessey
and Johnson [13] (Figure 1B). As expected, the secondary content
was composed entirely of b-structure and random coil and was
devoid of a-helical structure.
KIR2DS1 Oligomerization
During the refolding (see Materials and Methods) of KIR2DS1,
visible protein aggregates was always observed in the final dialysis
step containing 10 mM Tris-HCl, 150 mM sodium chloride and
0.4 mM sodium azide. We therefore carried out an extensive
Figure 3. Atomic force microscopic analysis of KIR2DS1 oligomerization. Two representative images are presented.
doi:10.1371/journal.pone.0023052.g003
Figure 2. Particle size distribution of KIR2DS1.
doi:10.1371/journal.pone.0023052.g002 Figure 4. KIR2DS1 oligomerization time course study. Circular
dichroism spectra were aquired over a period of 5 days on the same
KIR2DS1 sample.
doi:10.1371/journal.pone.0023052.g004
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search for buffer conditions that would promote greater solubility
of KIR2DS1, following the method of Lepre and Moore (1998).
Seven buffer species, pH, salt, and TFE concentration were all
varied and in total, 23 different buffer conditions were assessed
(Figure S1). However, in all cases, no differences in the level of
visible aggregation were observed. Additionally, no protein peaks
were observed in solution NMR spectra that were acquired for
several of the samples, indicating there was no substantial portion
of the sample with a molecular weight sufficiently small to observe
via this technique. The insensitivity of the observed aggregation to
changes in buffer conditions suggested this behaviour was perhaps
not the result of the commonly encountered situation where a
protein behaves non-ideally in a laboratory context, but could
instead derive from a well-defined, possibly functional self-
association.
To probe this possibility, we carried out dynamic light scattering
to determine the average apparent hydrodynamic diameter of the
extracellular portion of KIR2DS1 in solution, using a Zetasizer
Nano ZS instrument. The size distribution calculated by the Nano
software is derived from a non-negative least squares (NNLS)
analysis, and it was found that KIR2DS1 (3 mM) in a 10 mM Tris-
HCl, 150 mM sodium chloride and 0.4 mM sodium azide buffer
had a mean hydrodynamic diameter of 320 nm (Figure 2).
Since the hydrodynamic diameter measured by DLS depends
on the shape, as well as the size of the particles under study, we
next proceeded to use atomic force microscopy to visualize the
self-association of KIR2DS1 (Fig. 3). In all scanned regions,
KIR2DS1 self-associated in rod-like shapes of similar dimensions,
suggesting that the KIR2DS1 self-association is a well-defined
process. The measured dimensions indicate that the diameter of
the self-associated KIR2DS1 on the mica surface is 340 nm.
Figure 6. Working model for the role of KIR2DS1 in innate immunity.
doi:10.1371/journal.pone.0023052.g006
Figure 5. The concentration dependence of KIR2DS1 oligo-
merization. Optical density measurements at 350 nm were conducted
on various concentrations of KIR2DS1 (10, 25 and 50 mM). The hours
denote the time, after placing the protein in the first refolding buffer,
that visible aggregates were observed.
doi:10.1371/journal.pone.0023052.g005
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As mentioned earlier, during the refolding of KIR2DS1, visible
protein aggregates are observed in final dialysis step. To
investigate the self-association in further detail, we carried out a
time course measurement using circular dichroism spectroscopy
immediately after refolding. A freshly refolded KIR2DS1 sample
was centrifuged and the supernatant was concentrated to a final
concentration of 5 mM in 10 mM Tris-HCl, 150 mM sodium
chloride and 0.4 mM sodium azide. The protein sample was then
monitored for a period of 5 days. After the first day, small changes
can be observed in the spectrum (Fig. 4). For the next 3 days the
secondary structure of KIR2DS1 remained constant. However, on
the fifth day, the intensity of the spectrum decreased by ,85%
(Fig. 5). The decrease in the intensity of the spectrum is most likely
the result of KIR2DS1 self-association, and eventually, aggregate
formation of the protein. We speculate that the self-associated
KIR2DS1, whose surface area is less exposed than it would be for
the same concentration of free, non-associated protein, results in a
reduced total amount of the optically active protein available and
hence, a reduction in the intensity of the spectrum.
The KIR2DS1 self-association process is also dependent upon
its concentration, as determined by light scattering at 350 nm
(Fig. 5). It can be seen in Figure 5 that higher concentrations of
KIR2DS1 exhibit an increased degree of light scattering,
suggesting that the self-association of these samples are increased.
Also, higher concentrations of KIR2DS1 showed visible signs of
aggregation at earlier time points during the refolding of the
protein (100 mM – 72 hours (3 M urea); 25 mM – 96 hours (2 M
urea); 10 mM – 120 hours (1 M urea). Aggregation now occurs at
earlier time points due to the fact that the concentration is
increased.
Discussion
To date, there has been no study that has directly examined the
structure and/or self-association of KIR2DS1. Snyder et al. [14]
have designed a model of KIR2DL2 oligomerization based on the
protein-protein contacts observed in the crystal [15]. KIR2DS1
shares ,90% homology with the above members (KIR2DL1 and
KIR2DL2) and it would seem realistic that KIR2DS1 would self-
associate as well.
Circular dichroism spectroscopy revealed that the KIR2DS1 is
devoid of a-structure and contains a mixture of ß- and random
structure consistent with the previously crystallized KIRs
(KIR2DL1, KIR2DL2, KIR2DL3, KIR2DS2, KIR2DS4)
[15,14,16,17,18]. In contrast to x-ray crystal structures where
the protein is not studied in solution, we applied a variety of
techniques to KIR2DS1 in solution. Using CD, DLS and AFM,
we provide the first evidence for the self-association of KIR2DS1
in solution. More importantly, results from the AFM data reveals
that KIR2DS1 self-associates in a rod-like shape and suggests that
this self-association is a well-defined process.
Ligand-induced receptor aggregation is a common mechanism
for receptor-mediated signalling in immune responses [19,20].
However, although this may be assumed to be the case for KIRs,
there is very little or no evidence that this occurs in these receptors.
The results presented here allow us to define a working model for
the KIR2DS1- HLA class I molecules. The innate immune system
is one of the first defense strategies, and in such a case, ligand-
induced receptor aggregation on the surface of NK cells would
appear to be inefficient. First of all, once an antigen enters the host
system, the NK cell and the antigen have to be close enough in
proximity for the antigen-receptor interaction to occur. Secondly,
the NK KIR2DS1 receptors would have to be localized to a
common region in order to initiate the aggregation process, which
in turn, would lead to activation of DAP12 signalling cascade.
Alternatively, our working model proposes that the KIR2DS1
receptor oligomerize prior to their interaction with their HLA-
Class I counterparts (Fig. 6). In this model, the interaction between
antigen and ‘‘self-associated’’ KIR2DS1 then leads to the
activation of DAP12 signalling cascade.
Supporting Information
Figure S1 Examination of KIR2DS1 solubility under
various conditions.
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